A non-interventional study on patients changing to Xarelto® for treatment of venous thromboembolism (VTE) and prevention of recurrent VTE in patients with active cancer - EUPAS12608. COSIMO Cancer associated thrombosis – patient reported outcomes with rivaroxaban
Im Internet (Stand: 21.12.2021):